These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33636906)

  • 1. Oral Fluid Drug Testing in Pain Management Practice: Factors to Consider Before Choosing the Alternative Biological Matrix.
    Lee D
    J Appl Lab Med; 2018 Jan; 2(4):598-609. PubMed ID: 33636906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine and oral fluid drug testing in support of pain management.
    Kwong TC; Magnani B; Moore C
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of oxycodone concentrations in oral fluid.
    Moore C; Kelley-Baker T; Lacey J
    J Opioid Manag; 2012; 8(3):161-6. PubMed ID: 22798176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current technologies and considerations for drug bioanalysis in oral fluid.
    Gallardo E; Barroso M; Queiroz JA
    Bioanalysis; 2009 Jun; 1(3):637-67. PubMed ID: 21083159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of oral fluid tests for drugs of abuse.
    Cone EJ; Huestis MA
    Ann N Y Acad Sci; 2007 Mar; 1098():51-103. PubMed ID: 17332074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results.
    Desrosiers NA; Huestis MA
    J Anal Toxicol; 2019 Jul; 43(6):415-443. PubMed ID: 31263897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
    Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
    J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
    Busardò FP; Jones AW
    Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder.
    Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O
    Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures.
    Zheng Y; Sparve E; Sparring S; Bergström M
    J Anal Toxicol; 2021 Jan; 44(9):1004-1011. PubMed ID: 32128555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction.
    Ransohoff JR; Petrides AK; Piscitello GJ; Flood JG; Melanson SEF
    Drug Alcohol Depend; 2019 Oct; 203():8-12. PubMed ID: 31394416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Use by Music Festival Attendees: A Novel Triangulation Approach Using Self-Reported Data and Test Results of Oral Fluid and Pooled Urine Samples.
    Gjerde H; Gjersing L; Baz-Lomba JA; Bijlsma L; Salgueiro-González N; Furuhaugen H; Bretteville-Jensen AL; Hernández F; Castiglioni S; Johanna Amundsen E; Zuccato E
    Subst Use Misuse; 2019; 54(14):2317-2327. PubMed ID: 31398072
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.
    Heltsley R; Depriest A; Black DL; Crouch DJ; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2012 Mar; 36(2):75-80. PubMed ID: 22337775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.